As far as I am aware, the answer to the original question is a no.
Australia uses evidence based practice. Meaning anything done by a healthcare professional SHOULD always be able to fall back onto research to justify their actions.
Therefore a GP would be taking one hell of a risk by prescribing a drug meant for one use, for another, without the backing of research to suggest its appropriate.
Happy to be proven wrong, but I'm fairly confident its a no, that would defeat the entire purpose of doing all of these studies in the first place if a GP could go "hmmm lets have a go at using Ventolin to cure athletes foot, it might work, lets have a crack"
- Forums
- ASX - By Stock
- NEU
- Application
Application, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.34 |
Change
0.235(1.17%) |
Mkt cap ! $2.607B |
Open | High | Low | Value | Volume |
$20.39 | $20.53 | $20.14 | $1.559M | 76.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 53 | $20.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.35 | 4 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 164 | 20.350 |
6 | 285 | 20.340 |
6 | 436 | 20.330 |
6 | 390 | 20.320 |
3 | 411 | 20.310 |
Price($) | Vol. | No. |
---|---|---|
20.370 | 182 | 11 |
20.380 | 184 | 2 |
20.390 | 689 | 12 |
20.400 | 436 | 4 |
20.410 | 253 | 3 |
Last trade - 14.14pm 26/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |